Australia TGA To Hold May, June Seminars On New Device Regulation Laws
This article was originally published in The Gray Sheet
Executive Summary
Australia's Therapeutic Goods Administration will draft guidance documents explaining legislative requirements under the recently enacted Therapeutic Goods Amendment (Medical Devices) Bill and the Therapeutic Goods (Charges) Amendment Bill
You may also be interested in...
Regulatory News In Brief
Contraceptive advisory: Norplant contraceptive recipients can discontinue use of any "backup, non-hormonal method of birth control," developer Wyeth and FDA agree. Wyeth had advised doctors in October 2000 to discontinue implanting the system from lots going into distribution beginning in October 1999, based on concern about lower-than-expected release of the hormone levonorgestrel from the implants. Though the concerns have been resolved, Wyeth will stop selling the six-capsule Norplant system due to limitations in the component supply and therefore recommends women implanted with the devices seek alternative contraceptive methods when their implants expire...
Regulatory News In Brief
Contraceptive advisory: Norplant contraceptive recipients can discontinue use of any "backup, non-hormonal method of birth control," developer Wyeth and FDA agree. Wyeth had advised doctors in October 2000 to discontinue implanting the system from lots going into distribution beginning in October 1999, based on concern about lower-than-expected release of the hormone levonorgestrel from the implants. Though the concerns have been resolved, Wyeth will stop selling the six-capsule Norplant system due to limitations in the component supply and therefore recommends women implanted with the devices seek alternative contraceptive methods when their implants expire...
Australia Drafting New In Vitro Diagnostic Legislation
An Australian expert panel on in vitro diagnostics is drafting a discussion paper addressing regulatory reform of IVDs. The document is expected to be available for comment in July